Vera Therapeutics, Inc. (VERA)
34.19
-0.41
(-1.18%)
USD |
NASDAQ |
Aug 28, 16:00
34.22
+0.03
(+0.09%)
After-Hours: 20:00
Vera Therapeutics Market Cap : 2.460B for Aug. 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 28, 2026 | 2.460B |
| August 27, 2026 | 2.490B |
| August 26, 2026 | 2.649B |
| August 25, 2026 | 2.539B |
| August 24, 2026 | 2.426B |
| August 21, 2026 | 2.322B |
| August 20, 2026 | 2.249B |
| August 19, 2026 | 2.322B |
| August 18, 2026 | 2.323B |
| August 17, 2026 | 2.276B |
| August 14, 2026 | 2.276B |
| August 13, 2026 | 2.079B |
| August 12, 2026 | 2.158B |
| August 11, 2026 | 2.180B |
| August 10, 2026 | 2.272B |
| August 07, 2026 | 2.367B |
| August 06, 2026 | 2.304B |
| August 05, 2026 | 2.177B |
| August 04, 2026 | 2.148B |
| August 03, 2026 | 2.312B |
| July 31, 2026 | 2.303B |
| July 30, 2026 | 2.371B |
| July 29, 2026 | 2.332B |
| July 28, 2026 | 2.390B |
| July 27, 2026 | 2.523B |
| Date | Value |
|---|---|
| July 24, 2026 | 2.543B |
| July 23, 2026 | 2.607B |
| July 22, 2026 | 2.586B |
| July 21, 2026 | 2.666B |
| July 20, 2026 | 2.653B |
| July 17, 2026 | 2.762B |
| July 16, 2026 | 2.806B |
| July 15, 2026 | 3.049B |
| July 14, 2026 | 3.094B |
| July 13, 2026 | 2.977B |
| July 10, 2026 | 3.013B |
| July 09, 2026 | 3.045B |
| July 08, 2026 | 3.044B |
| July 07, 2026 | 3.082B |
| July 06, 2026 | 2.879B |
| July 02, 2026 | 2.955B |
| July 01, 2026 | 3.060B |
| June 30, 2026 | 3.078B |
| June 29, 2026 | 3.095B |
| June 26, 2026 | 3.046B |
| June 25, 2026 | 2.905B |
| June 24, 2026 | 2.834B |
| June 23, 2026 | 2.740B |
| June 22, 2026 | 2.757B |
| June 18, 2026 | 2.517B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 11.98B |
| Oncolytics Biotech, Inc. | 106.76M |
| Sangamo Therapeutics, Inc. | 66.49M |
| Sarepta Therapeutics, Inc. | 2.203B |
| Anixa Biosciences, Inc. | 118.05M |
Market Cap Related Metrics
| PEG Ratio | -0.0911 |
| Price to Book Value | 6.033 |
| Price | 34.19 |
| Earnings Yield | -17.17% |
| PEGY Ratio | -0.0911 |